The industry of tissue engineering and cell therapy, while nascent in many ways due to the great, as yet largely untapped potential, has spawned a large number of companies. Many are focusing on areas only recently (some would argue still) very much in pure research. But many are also commercially successful with approved clinical products actively treating diseases in wound management, orthopedics, and a growing range of other applications.
MedMarket Diligence is completing a global analysis of tissue and cell therapy markets. Report #S520 includes coverage more than 150 companies. See "Tissue Engineering, Cell Therapy and Transplantation: Products, Technologies & Market Opportunities, Worldwide, 2009-2018."See Report #S520.